Skip to content

Roxanne Macaskill

Trillium Health Partners/Clinical Program Director

2025 Salary

$215,227

Total compensation $216,079, including $851 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2025

Employer Rank

#49

Trillium Health Partners

Years on List

5

2021–2025

Peak Salary

$215,227

2025

Full 2025 roster at Trillium Health Partners·See where $215,227 ranks →

Total Compensation History

Total compensation by yearLine chart of 5 yearly values of total compensation, from $142,864 in 2021 to $216,079 in 2025.$100K$125K$150K$175K$200K$225K20212022202320242025
Total compensation, 2021–2025. Axis starts at $100,000, the Sunshine List disclosure threshold.

Full History
20212025

$142,468 in 2021 is worth about $165,206 in 2025 dollars.

Take-Home Pay
(After Tax) · 2025 estimate

Of the $215,227 Roxanne Macaskill earned in 2025, roughly $138,431 would remain after income tax, CPP and EI, an all-in deduction rate of about 35.7%. Among those listed as Clinical Program Director in 2025, the median was $210,499; this salary sits about 2% above it. Roxanne Macaskill has appeared on the list 5 times since 2021. Pension contributions — likely HOOPP in the Hospitals & Boards of Public Health sector — would typically trim another 7–10% off that figure.

Estimated net pay
~$138,431
Effective income-tax rate (excl. CPP/EI)
~33.1%
CPP + EI contributions
~$5,507
All-in deduction rate (incl. CPP/EI)
~35.7%
vs. 2025 Clinical Program Director median
+2%

Where does $215,227 rank on the Sunshine List? →

Estimate only: 2025 federal and Ontario rates, basic personal amounts, Canada employment amount and CPP/EI credits; single, employment income only, salary treated as full-year income. Ignores pension contributions (OMERS, HOOPP, OTPP, OPTrust and similar plans lower actual take-home), union dues, RRSPs and benefits.

Also at Trillium Health Partners
2025

View all 3,290 employees at Trillium Health Partners (2025) →